Use of the Sentinel System to Examine Medical Product Use and Outcomes During Pregnancy
- PMID: 38940904
- DOI: 10.1007/s40264-024-01447-z
Use of the Sentinel System to Examine Medical Product Use and Outcomes During Pregnancy
Abstract
While many pregnant individuals use prescription medications, evidence supporting product safety during pregnancy is often inadequate. Existing electronic healthcare data sources provide large, diverse samples of health plan members to allow for the study of medical product utilization during pregnancy, as well as pregnancy, maternal, and infant outcomes. The Sentinel System is a national medical product surveillance system that includes administrative claims and electronic health record databases from large national and regional health insurers. In addition to these data sources, Sentinel develops and maintains a sizeable selection of analytic tools to facilitate epidemiologic analyses in a way that protects patient privacy and health system autonomy. In this article, we provide an overview of Sentinel System infrastructure, including the Mother-Infant Linkage Table, parameterizable analytic tools, and algorithms to estimate gestational age and identify pregnancy outcomes. We also describe past and future Sentinel work that contributes to our understanding of the way medical products are used and the safety of these products during pregnancy.
© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
References
-
- van der Graaf R, van der Zande ISE, den Ruijter HM, Oudijk MA, van Delden JJM, Oude Rengerink K, et al. Fair inclusion of pregnant women in clinical trials: an integrated scientific and ethical approach. Trials. 2018;19:78. https://doi.org/10.1186/s13063-017-2402-9 . - DOI - PubMed - PMC
-
- Lupattelli A, Trinh NTH, Nordeng H. Association of maternal personality traits with medication use during pregnancy to appraise unmeasured confounding in long-term pharmacoepidemiological safety studies. Front Pharmacol. 2023;14:1160168. https://doi.org/10.3389/fphar.2023.1160168 . - DOI - PubMed - PMC
-
- Kazma JM, Van Den Anker J, Ahmadzia HK. Pharmacoethics and pregnancy: overcoming the therapeutic orphan stigma. Br J Clin Pharmacol. 2023;89:483–90. https://doi.org/10.1111/bcp.15173 . - DOI - PubMed
-
- Casella C, Lo Giudice M, Niola M, Di Lorenzo P, Adamo M, Bianco C, et al. Need for fair inclusion of pregnant women in clinical trials: scientific and ethical considerations about the lesson from the COVID-19 vaccines development. Minerva Obstet Gynecol. 2022. https://doi.org/10.23736/S2724-606X.21.04922-8 . - DOI - PubMed
-
- Rabinowitz LG, Rabinowitz DG, Silver EM, Oxentenko AS, Williams KE, Silver JK. Disparities persist in inclusion of female, pregnant, lactating, and older individuals in inflammatory bowel disease clinical trials. Gastroenterology. 2022. https://doi.org/10.1053/j.gastro.2022.03.016 . - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous